Navigation Links
Real Time Genomics and Knome Ink Deal to Integrate and Sell the RTG Variant Platform on knoSYS100 System
Date:5/6/2013

SAN FRANCISCO, CA (PRWEB) May 06, 2013

Real Time Genomics, Inc., the genome analytics company, and Knome, Inc., the human genome interpretation company, today announced that the Real Time Genomics (RTG) Variant platform will be integrated into every shipment of the knoSYS™100 interpretation system. The agreement enables customers to easily purchase the RTG analytics engine as an upgrade to the system. The product will combine two world-class commercial platforms to deliver end-to-end genome analytics and interpretation with superior accuracy and speed. Financial terms of the agreement were not disclosed.

“In the past year demand for genome interpretation has surged as translational researchers and clinicians adopt sequencing for human disease discovery and diagnosis,” said Wolfgang Daum, CEO of Knome. “Concomitant with that demand is the need for accurate and easy-to-use industrial grade analysis that meets expectations of clinical accuracy. The RTG platform is both incredibly fast and truly differentiating to customers doing family studies, and we are excited to add such a powerful platform to the knoSYS ecosystem.”

The partnership simplifies the purchasing process by allowing knoSYS customers to purchase the RTG platform directly from Knome sales representatives.

“The Knome system is a perfect complementary channel to further expand our commercial effort to bring the RTG platform to market,” said Steve Lombardi, CEO of Real Time Genomics. “Knome has built a recognizable brand around human clinical genome interpretation, and by delivering the RTG platform within their system, both company’s are simplifying genomics to help customers understand human disease and guide clinical actions.”

About Real Time Genomics

Real Time Genomics (http://www.realtimegenomics.com) has a passion for genomics. The company offers software tools and applications for the extraction of unique value from genomes. Its competency lies in applying the combination of its patented core technology and deep computational expertise in algorithms to solve problems in next generation genomic analysis. Real Time Genomics is a private San Francisco based company backed by investment from Catamount Ventures, Lightspeed Venture Partners, and GeneValue Ltd.

About Knome

Knome Inc. is a leading provider of human genome interpretation systems and services. Knome provides tools and solutions that help researchers, drug developers, and clinicians determine the genetic basis of human disease and drug response. Designed to accelerate and industrialize the process of interpreting whole genomes, Knome’s big data technologies are helping to pave the healthcare industry’s transition to molecular-based, precision medicine.

Press contact for Real Time Genomics:
Jason Blue-Smith
jason(at)realtimegenomics(dot)com
(415) 420-4574

Press contact for Knome:
Jonas Lee
jlee(at)knome(dot)com
(617) 715-1000 x7001

Read the full story at http://www.prweb.com/releases/2013/5/prweb10703039.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Real Time Genomics and J. Craig Venter Institute Embark on Strategic Research Initiative
2. Nimbix and Convey Partner for “The Accelerated Genomics Cloud” (TAGC) Promotion
3. Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical Laboratories
4. Real Time Genomics and Omicia Partner on a Platform for Integrated Genomic Analysis for Childhood Disease
5. Venter Institute-Led Team Recovers and Sequences Genome of Periodontal Pathogen from Biofilm in Hospital Sink using Single-Cell Genomics
6. Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
7. Squished bug genomics: Insect goo aids biodiversity research
8. BGI-Shenzhen Completes Acquisition of Complete Genomics
9. Genomics Data Management Leader Annai Systems Offers Shortcut to Analysis
10. Real Time Genomics Announces Formation of its Scientific Advisory Board
11. Real Time Genomics® Announces Platform Launch, Expanding Commercial Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/7/2020)... ... April 06, 2020 , ... Gateway Genomics , ... reached 200,000 SneakPeek Early Gender DNA Tests sold in March, just months ... launched as an ecommerce product, where a mom could order her kit online, collect ...
(Date:4/1/2020)... ... March 30, 2020 , ... Kinetic ... ArmourGuard® RTU, an EPA-approved spray-on antimicrobial solution. As a first-of-its-kind technology within the ... continual antimicrobial activity against microorganisms for up to 90 days. , In addition ...
(Date:4/1/2020)... ... March 31, 2020 , ... ... (MBS) has developed a method using its revolutionary NEXTGENPCR endpoint thermocycler and ... with smaller reaction volumes, increased samples per run, and standard, affordable laboratory ...
(Date:4/1/2020)... ... 31, 2020 , ... Bedoukian Research, Inc. (BRI) ... Development Agreement that builds on each company’s expertise in developing efficient routes to ... supply of high-quality insect pheromones as well as flavors and fragrances. P2 has ...
Breaking Biology Technology:
(Date:5/21/2020)... ... May 20, 2020 , ... Catalent, ... drugs, biologics, cell and gene therapies, and consumer health products, today announced that ... be presenting at the ISCT 2020 Paris Virtual conference, which takes place on ...
(Date:5/14/2020)... ... May 13, 2020 , ... DuPont Nutrition & ... for the lactose-free dairy market. This unique product allows for process optimization and ... at competitive costs across North America. , Among the numerous benefits Bonlacta™ offers, ...
(Date:5/1/2020)... LAUDERDALE, Fla. (PRWEB) , ... April 30, 2020 ... ... accredited telemedicine company backed by Siemens Healthineers and several healthcare VC firms announces ... COVID-19, the goal of CareDoctors.com is to enhance patient care experience by offering ...
Breaking Biology News(10 mins):